For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago

Justin Gover, CEO of British drugmaker GW Pharmaceuticals in a conversation with Biocom president and CEO Joe Panetta

Remember the simpler times of the mid-2010s, when you could order a latte or cocktail in California without the option…

Full text: https://xconomy.com/san-diego/2019/08/26/for-gw-pharma-ceo-justin-gover-the-cbd-trend-started-20-years-ago/

Author

Sarah de Crescenzo

Source

xconomy, 2019-08-26.

Supplier

BIOCOM AG
GW Pharmaceuticals
UK Government
US Drug Enforcement Administration (DEA)

Share

More news